News and information for patients.
I have always been fascinated by happy coincidences. It makes me think of the experiences that connect you to people in the most surprising ways. Such was the case recently with a promotion we ran at
This video episode in our Grand Rounds series is a thirteen-minute excerpt from our hour-long presentation on pituitary surgery. It focuses on the current practice by some surgeons that consider surgery for pituitary tumors in the cavernous sinus and discusses the procedure’s issues, benefits, pitfalls, and risks.
We often scan the pituitary universe and report on the latest drug developments, new potential therapies, and engaging clinical cases and resources. We hope this knowledge helps people gain more insight into these complicated diseases and the fascinating medical/scientific discovery, research, and diagnosis world.
From Jorge D. Faccinetti, co-founder and chief editor: Why can’t we address some of the most critical issues affecting healthcare today? These are not just other people’s problems. They affect us, our doctors, and our
From JD Faccinetti, co-founder and chief editor – I like to ramble, so here it goes. I was musing about how unique and essential this little gland is—the size of a pea, the pituitary runs almost
From J D Faccinetti, chief editor co-founder – First, some background: the latest edition of the WHO (World Health Organization) Endocrine Tumors and Central Nervous System Tumors group reclassified pituitary adenomas as neuroendocrine tumors or
A recent article in Oxford Academic Press reviews the state of research and development of age-related hormonal changes, focusing on understanding the factors that cause those changes with the goal of improving health. Future activities in this area, guided by this scientific statement, will be particularly relevant to those 65 years and older.
In a recent JAMA Network article covering the COVID-19 pandemic, 23.3% of physicians reported personal attacks on social media. Online bullying and social media harassment are nothing new, but this behavior, plus considerable misinformation, makes disseminating helpful, accurate content an ongoing challenge.
Cihan Atila, M.D., principal investigator Department of Endocrinology, Diabetology and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland, reports that now, for the first time, researchers from the University of Basel and the University
From the editor’s desk – One of the challenges for us at PWN is keeping content from years past easy to find and available to our readers.
The World Orphan Drug Congress slated for May 23 to 25 in Washington DC, brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors, and solution providers to meet and
From the “Got Diabetes Insipidus” support group comes this very helpful guide from Drs. Christ-Crain and Atila – University Hospital Basel – to help in the management of AVP-D (arginine vasopressin deficiency, formerly diabetes insipidus)
This week’s Live-talk offers critical knowledge that people affected with pituitary and endocrine diseases need to know to ensure they receive proper treatment. Dr. Sylvia Asa, a pioneer in endocrine and pituitary tumor pathology, talks with Dr. Lewis Blevins about her work in the field and the reclassification of pituitary adenomas to Pituitary Neuroendocrine Tumors, or PitNets.